Cerdulatinib
CAS: 1198300-79-6
Ref. IN-DA008TF1
| 1mg | 52.00 € | ||
| 5mg | 81.00 € | ||
| 10mg | 102.00 € | ||
| 25mg | 160.00 € | ||
| 50mg | 145.00 € | ||
| 100mg | 242.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Product Information
Name:
Cerdulatinib
Synonyms:
- 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide
- 4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide
- 4-(Cyclopropylamino)-2-((4-(4-(ethanesulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide
- 4-(cyclopropylamino)-2-({4-[4-(ethanesulfonyl)piperazin-1-yl]phenyl}amino)pyrimidine-5-carboxamide
- 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide
- 5-Pyrimidinecarboxamide, 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)-1-piperazinyl)phenyl)amino)-
- 5-Pyrimidinecarboxamide, 4-(cyclopropylamino)-2-[[4-[4-(ethylsulfonyl)-1-piperazinyl]phenyl]amino]-
- PRT 062070
- PRT 2017
- 4-(Cyclopropylamino)-2-[[4-[4-(ethylsulfonyl)-1-piperazinyl]phenyl]amino]-5-pyrimidinecarboxamide
- See more synonyms
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Indagoo
Long term storage:
Notes:
Chemical properties
Molecular weight:
445.5385
Formula:
C20H27N7O3S
Purity:
98%
Color/Form:
Solid
InChI:
InChI=1S/C20H27N7O3S/c1-2-31(29,30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8,13-14H,2-4,9-12H2,1H3,(H2,21,28)(H2,22,23,24,25)
InChI key:
BGLPECHZZQDNCD-UHFFFAOYSA-N
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: IN-DA008TF1 Cerdulatinib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
